A valuable and inexpensive strategy
Across Cibitoke, MSF teams are supporting 20 health centers, where each child receives four doses of the RTS,S malaria vaccine between the ages of six and 18 months. At the time of the first vaccination, the family is given an insecticide-treated mosquito net. Between the ages of nine and 24 months, these children also receive additional protection in the form of sulfadoxine/pyrimethamine tablets, known as “perennial malaria chemoprevention.”
At the Kaburantwa Medical Center, one of the facilities MSF supports as part of this program, a long line of parents waiting outside reflects their eagerness to protect their children.
“When he was younger, my son often suffered from malaria,” says Claudine Tuyishimire as she leaves the center after having her youngest child, nine-month-old Fanny, vaccinated. “He was even hospitalized and had to receive a blood transfusion. When they explained the protection available today, I didn’t hesitate. I came straight away. Thanks to this, children will rarely fall ill, and parents will no longer have to come to the hospital so often.”
Across all the centers involved in implementing this approach, the enthusiasm is similar. Waiting rooms remain full. This high turnout is also the result of awareness and follow-up campaigns conducted by community health workers among families and associations, particularly women’s groups.
“The scale of the problem, as well as the costs the disease imposes on households, are generating strong enthusiasm within communities,” explains Adélaïde Ouabo, MSF country coordinator in Burundi. “The medical costs of treating malaria—especially in its severe forms—are a heavy burden on families and on the Burundian health system. These massive costs contrast with the low investment required to implement the triple protection strategy.”
MSF's work with the Ministry of Health in Cibitoke shows that implementing this system is both simple and inexpensive compared to the benefits it brings. Malaria vaccination and mosquito net distribution are already integrated into the health system, and preventive treatment drugs are low-cost. The approach is therefore easily absorbed by the health system and replicable elsewhere in the country.